Douglas A. Jabs, M.D., M.B.A. is an internationally-recognized expert in the evaluation and management of patients with uveitis and related immune-mediated ocular disorders, particularly on the use of immunosuppression to treat severe ocular inflammatory diseases. Founder of the Division of Ocular Immunology and Uveitis at Wilmer, he now is the Director of the Center for Clinical Trials and Evidence Synthesis at the Johns Hopkins University Bloomberg School of Public Health. Dr. Jabs is rated as an Advanced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Uveitis, CMV Retinitis, Scleritis, Cataract Removal, and Trabeculectomy.

Bryn M. Burkholder, M.D., is an assistant professor of ophthalmology at the Wilmer Eye Institute and the Antoinette R. Schifanelli Rising Professor of Ophthalmology, specializing in ocular inflammatory and infectious diseases, cataract surgery and comprehensive ophthalmology. Dr. Burkholder earned her bachelor's degree from Duke University, where she majored in biology, and received her medical degree from the University of Pennsylvania. After completing an internship at the Albert Einstein Medical Center in Philadelphia, she moved to Baltimore for her residency in ophthalmology at the Wilmer Eye Institute. Dr. Burkholder remained at Wilmer for her fellowship training in uveitis before joining the faculty in July 2012. Dr. Burkholder is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. Her top areas of expertise are Uveitis, Scleritis, Neuroretinitis, Episcleritis, and Cataract Removal.

Meghan Berkenstock, M.D., is an associate professor of ophthalmology at the Johns Hopkins Wilmer Eye Institute. She specializes in ocular inflammatory and infectious diseases, cataract surgery, and comprehensive ophthalmology. Since joining the faculty of the Wilmer Eye Institute in 2016, she has established a research focus on risk reduction and quality assurance initiatives in the care of patients with uveitis. She has implemented several initiatives to improve laboratory monitoring and understanding barriers to care in patients on immunosuppressive medications. The bulk of her research focuses on identifying ocular adverse events (IRAE) associated with the use of immunotherapy agents in the treatment of systemic malignancies. She is a member and the only ophthalmologist on the National Comprehensive Cancer Network Panel on developing guidelines to treat IRAEs. Dr. Berkenstock is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. Her top areas of expertise are Scleritis, Episcleritis, Uveitis, Vitrectomy, and Cataract Removal.

Allen O. Eghrari, M.D., M.P.H., is director of the Dana Center for Preventive Ophthalmology at the Wilmer Eye Institute and associate professor of ophthalmology at the Johns Hopkins University School of Medicine. He specializes in cornea, cataract and external eye diseases at the Wilmer Eye Institute's locations in Baltimore and Belcamp, Maryland. Dr. Eghrari treats a wide range of eye conditions, with special interest in Fuchs' dystrophy, cataract surgery, cornea transplantation including Descemet Membrane Endothelial Keratoplasty, and Ebola-associated eye disease. Dr. Eghrari received his M.D. degree from the Johns Hopkins University School of Medicine and M.P.H. from the Johns Hopkins Bloomberg School of Public Health. He completed both residency training in ophthalmology and subspecialty fellowship in cornea and cataract surgery at the Wilmer Eye Institute. Dr. Eghrari is a recipient of the Claes Dohlman Society Fellowship Award, the ARVO/Alcon Early Career Clinician-Scientist Award, and the Research to Prevent Blindness Special Scholar Award. Dr. Eghrari is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Fuchs Dystrophy, Macular Corneal Dystrophy Type 1, Cataract, Corneal Transplant, and Cataract Removal.

Kenneth Taubenslag is an Ophthalmologist in Baltimore, Maryland. Dr. Taubenslag is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Endophthalmitis, Neuroretinitis, Uveitis, Trabeculectomy, and Vitrectomy. Dr. Taubenslag is currently accepting new patients.

Sharon D. Solomon, M.D., is the Katharine M. Graham Professor of Ophthalmology at the Wilmer Eye Institute. A retina specialist and ophthalmologist, Dr. Solomon's clinical expertise includes medical and surgical treatment of age-related macular degeneration, diabetic retinopathy, epiretinal membranes, macular holes, and retinal tears and detachment. Dr. Solomon has a large national and international referral practice at Wilmer. Dr. Solomon has served as principal investigator at Wilmer on a number of NIH-sponsored clinical trials. She has numerous publications from her clinical trials involvement. Dr. Solomon received her bachelor's degree in biochemistry from Harvard University and her medical degree from the University of California, San Francisco. After her internship at Stanford, she returned to UCSF for her residency in ophthalmology. Dr. Solomon completed her surgical retina fellowship at the Wilmer Eye Institute prior to joining the faculty. Dr. Solomon is a member of the prestigious Miller-Coulson Academy of Clinical Excellence at Johns Hopkins. Dr. Solomon is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. Her top areas of expertise are Retinal Vein Occlusion, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Gyrate Atrophy of the Choroid and Retina, and Vitrectomy.

Sidney Schechet is an Ophthalmologist in Baltimore, Maryland. Dr. Schechet is rated as an Experienced provider by MediFind in the treatment of Vogt-Koyanagi-Harada Disease. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Diabetic Retinopathy, Retinal Detachment, and Vitrectomy. Dr. Schechet is currently accepting new patients.